Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CELL PREPARATION
Document Type and Number:
WIPO Patent Application WO/2023/181830
Kind Code:
A1
Abstract:
Provided is a cell preparation that has effective therapeutic effect on ischemic diseases. The cell preparation contains CD18-positive cells. This cell preparation is produced by: acquiring a buffy coat layer from a sample containing hematopoietic stem cells; removing inhibitory cells that inhibit the therapeutic effect from the buffy coat layer to acquire mononuclear cells; acquiring CD34+ mononuclear cells that are CD34-positive from the mononuclear cells; and then acquiring CD34+CD18high mononuclear cells that highly express CD18 from the CD34-positive mononuclear cells.

Inventors:
TAGUCHI AKIHIKO (JP)
OKINAKA YUKA (JP)
OGAWA YUKO (JP)
KIMURA TAKAFUMI (JP)
TANAKA MITSUNOBU (JP)
YASUI KAZUTA (JP)
FUCHIZAKI AKIHIRO (JP)
Application Number:
PCT/JP2023/007766
Publication Date:
September 28, 2023
Filing Date:
March 02, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FOUNDATION FOR BIOMEDICAL RES AND INNOVATION AT KOBE (JP)
International Classes:
A61K35/12; A61K35/28; A61K35/51; A61P25/00; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P43/00; C12N5/0735; C12N5/074; C12N5/0775; C12N5/0789; C12N5/0797; C12N5/10
Foreign References:
US20070248998A12007-10-25
US20070031387A12007-02-08
Other References:
AKIHIKO TAGUCHI, TOSHIHIRO SOMA, HIDEKAZU TANAKA, TAKAYOSHI KANDA, HIROYUKI NISHIMURA, HIROO YOSHIKAWA, YOSHITANE TSUKAMOTO, HIROY: "Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 114, no. 3, 1 August 2004 (2004-08-01), GB , pages 330 - 338, XP008146070, ISSN: 0021-9738, DOI: 10.1172/JCI20622
MESA-NÚÑEZ CRISTINA, LEON-RICO DIEGO, ALDEA MONTSERRAT, DAMIÁN CARLOS, SANCHEZ-BALTASAR RAQUEL, SANCHEZ REBECA, ALBERQUILLA OMAIRA: "The downregulated membrane expression of CD18 in CD34+ cells defines a primitive population of human hematopoietic stem cells", STEM CELL RESEARCH & THERAPY, vol. 11, no. 1, 1 December 2020 (2020-12-01), pages 1 - 9, XP093095764, DOI: 10.1186/s13287-020-01672-0
Attorney, Agent or Firm:
MAEDA & PARTNERS (JP)
Download PDF: